BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35505580)

  • 1. Independent prognostic significance of TP53 mutations in adult acute myeloid leukaemia with complex karyotype.
    Xu N; Lai YY; Chen WM; Jiang H; Wang Y; Wang X; Zhao XS; Huang XJ; Jiang Q; Qin YZ
    Int J Lab Hematol; 2022 Oct; 44(5):892-899. PubMed ID: 35505580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia.
    Becker H; Pfeifer D; Ihorst G; Pantic M; Wehrle J; Rüter BH; Bullinger L; Hackanson B; Germing U; Kuendgen A; Platzbecker U; Döhner K; Ganser A; Hagemeijer A; Wijermans PW; Döhner H; Duyster J; Lübbert M
    Ann Hematol; 2020 Jul; 99(7):1551-1560. PubMed ID: 32504186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features of complex karyotype in newly diagnosed acute myeloid leukemia.
    Yoshida S; Onozawa M; Miyashita N; Kimura H; Takahashi S; Yokoyama S; Matsukawa T; Hirabayashi S; Mori A; Hidaka D; Minauchi K; Shigematsu A; Hashiguchi J; Igarashi T; Kakinoki Y; Tsutsumi Y; Ibata M; Kobayashi H; Haseyama Y; Fujimoto K; Ishihara T; Sakai H; Ota S; Kondo T; Teshima T
    Int J Hematol; 2023 Apr; 117(4):544-552. PubMed ID: 36572814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct mutation spectrum, clinical outcome and therapeutic responses of typical complex/monosomy karyotype acute myeloid leukemia carrying TP53 mutations.
    Leung GMK; Zhang C; Ng NKL; Yang N; Lam SSY; Au CH; Chan TL; Ma ESK; Tsui SP; Ip HW; So JCC; Ng MHL; Cheng KCK; Wong KF; Siu LLP; Yip SF; Lin SY; Lau JSM; Luk TH; Lee HKK; Lau CK; Kho B; Kwong YL; Leung AYH
    Am J Hematol; 2019 Jun; 94(6):650-657. PubMed ID: 30900772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent Prognostic Significance of Monosomy 17 and Impact of Karyotype Complexity in Monosomal Karyotype/Complex Karyotype Acute Myeloid Leukemia: Results from Four ECOG-ACRIN Prospective Therapeutic Trials.
    Strickland SA; Sun Z; Ketterling RP; Cherry AM; Cripe LD; Dewald G; Fernandez HF; Hicks GA; Higgins RR; Lazarus HM; Litzow MR; Luger SM; Paietta EM; Rowe JM; Vance GH; Wiernik P; Wiktor AE; Zhang Y; Tallman MS;
    Leuk Res; 2017 Aug; 59():55-64. PubMed ID: 28551161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic stem cell transplantation using HLA-matched donors for acute myeloid leukemia with deletion 5q or monosomy 5: a study from the Acute Leukemia Working Party of the EBMT.
    Poiré X; Labopin M; Polge E; Forcade E; Ganser A; Volin L; Michallet M; Blaise D; Yakoub-Agha I; Maertens J; Espiga CR; Cornelissen J; Finke J; Mohty M; Esteve J; Nagler A
    Haematologica; 2020; 105(2):414-423. PubMed ID: 31048355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT).
    Poiré X; Labopin M; Maertens J; Yakoub-Agha I; Blaise D; Ifrah N; Socié G; Gedde-Dhal T; Schaap N; Cornelissen JJ; Vigouroux S; Sanz J; Michaux L; Esteve J; Mohty M; Nagler A
    J Hematol Oncol; 2017 Jan; 10(1):20. PubMed ID: 28100265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytogentic and prognostic characteristic of acute myeloid leukemia with monosomal karyotype].
    Li Z; Wei H; Lin D; Zhou CL; Liu BC; Wang Y; Liu KQ; Li W; Gong BF; Wei SN; Zhang GJ; Zhao XL; Li Y; Liu YT; Gong XY; Gu RX; Qiu SW; Mi YC; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2016 May; 37(5):366-71. PubMed ID: 27210869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome.
    Rücker FG; Schlenk RF; Bullinger L; Kayser S; Teleanu V; Kett H; Habdank M; Kugler CM; Holzmann K; Gaidzik VI; Paschka P; Held G; von Lilienfeld-Toal M; Lübbert M; Fröhling S; Zenz T; Krauter J; Schlegelberger B; Ganser A; Lichter P; Döhner K; Döhner H
    Blood; 2012 Mar; 119(9):2114-21. PubMed ID: 22186996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of complex and/or monosomal karyotypes in post-transplant poor cytogenetic acute myeloid leukaemia: A quantitative approach.
    Jo T; Arai Y; Oshima S; Kondo T; Harada K; Uchida N; Doki N; Fukuda T; Tanaka M; Ozawa Y; Kuriyama T; Ikegame K; Katayama Y; Ota S; Ara T; Kawakita T; Onizuka M; Ichinohe T; Atsuta Y; Yanada M;
    Br J Haematol; 2023 Jul; 202(2):356-368. PubMed ID: 37211753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex and monosomal karyotype are distinct cytogenetic entities with an adverse prognostic impact in paediatric acute myeloid leukaemia. A NOPHO-DBH-AML study.
    Bager N; Juul-Dam KL; Sandahl JD; Abrahamsson J; Beverloo B; de Bont ESJM; Ha SY; Jahnukainen K; Jónsson ÓG; Kaspers GL; Kovalova Z; Lausen B; De Moerloose B; Noren-Nyström U; Palle J; Saks K; Zeller B; Kjeldsen E; Hasle H
    Br J Haematol; 2018 Nov; 183(4):618-628. PubMed ID: 30406946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemia.
    Loke J; Labopin M; Craddock C; Cornelissen JJ; Labussière-Wallet H; Wagner-Drouet EM; Van Gorkom G; Schaap NPM; Kröger NM; Veelken JH; Rovira M; Menard AL; Bug G; Bazarbachi A; Giebel S; Brissot E; Nagler A; Esteve J; Mohty M
    Cancer; 2022 Aug; 128(15):2922-2931. PubMed ID: 35612815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitance of monosomal karyotype with at least 5 chromosomal abnormalities is associated with dismal treatment outcome of AML patients with complex karyotype - retrospective analysis of Polish Adult Leukemia Group (PALG).
    Wierzbowska A; Wawrzyniak E; Siemieniuk-Rys M; Kotkowska A; Pluta A; Golos A; Robak T; Szarawarska M; Jaskowiec A; Duszenko E; Rybka J; Holojda J; Grosicki S; Pienkowska-Grela B; Woroniecka R; Ejduk A; Watek M; Wach M; Mucha B; Skonieczka K; Czyzewska M; Jachalska A; Klonowska A; Iliszko M; Knopinska-Posluszny W; Jarmuz-Szymczak M; Przybylowicz-Chalecka A; Gil L; Kopacz A; Holowiecki J; Haus O
    Leuk Lymphoma; 2017 Apr; 58(4):889-897. PubMed ID: 27561449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TP53 mutations are associated with very complex karyotype and suggest poor prognosis in newly diagnosed myelodysplastic syndrome patients with monosomal karyotype.
    Ren Y; Wang J; Zhang H; Mei C; Ye L; Luo Y; Zhou X; Zhu S; Jiang L; Wang L; Jin J; Tong H
    Asia Pac J Clin Oncol; 2020 Jun; 16(3):172-179. PubMed ID: 32030889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and molecular characteristics of acute myeloid leukemia and the dismal prognosis of
    Liu H; Shi Y; Tao S; Li Y; Wang C; Yu L
    Hematology; 2023 Dec; 28(1):2223866. PubMed ID: 37313982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double minute chromosomes in acute myeloid leukemia and myelodysplastic syndromes are associated with complex karyotype, monosomal karyotype,
    Wang N; Yuan L; Jing Y; Fan K; Jin H; Lv C; Wang L; Yu L
    Leuk Lymphoma; 2021 Oct; 62(10):2466-2474. PubMed ID: 33904352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Monosomal karyotype among adult acute myeloid leukemia: clinical characteristic and prognostic analysis].
    Feng R; Liu H; Chang N; Fan Y; Li J; Zhang Y; Chen W; Wang H; Tian Y; Pei L; Ning S; Xing B; Xu X
    Zhonghua Xue Ye Xue Za Zhi; 2014 May; 35(5):393-6. PubMed ID: 24857207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic implications of chromosome 17 abnormalities in the context of monosomal karyotype in patients with acute myeloid leukemia and complex cytogenetics.
    Nazha A; Kantarjian HM; Bhatt VR; Nogueras-Gonzalez G; Cortes JE; Kadia T; Garcia-Manero G; Abruzzo L; Daver N; Pemmaraju N; Quintas-Cardama A; Ravandi F; Keating M; Borthakur G
    Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):163-71. PubMed ID: 24461514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TP53 status and impact on AML prognosis within the ELN 2022 risk classification.
    Fleming S; Tsai XC; Morris R; Hou HA; Wei AH
    Blood; 2023 Dec; 142(23):2029-2033. PubMed ID: 37647854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical characteristics and therapeutic effect of TP53 variant in patients with acute leukemia].
    Mi R; Guo Z; Liu W; Hu J; Fan R; Chen L; Liu J; Wei X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Oct; 38(10):955-960. PubMed ID: 34625931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.